TGTX
Tg Therapeutics
$55.39
+$0.74 (+1.35%)Sep 10, 2026
Key metrics
The numbers that frame TGTX today
- Market cap
- $8.48B
- P/E (TTM)
- 19.2
- EV / FCF
- 503.1
- Gross margin
- 82.4%
- EV / Sales
- 10.9
- ROIC
- 10.3%
- Div yield
- 0%
- Debt / equity
- 1.2
- 52wk Low
- $26.76
- 52wk High
- $59.30
Growth
Revenue and earnings trend for TGTX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about TGTX
Is Tg Therapeutics a good buy?
Yes. Tg Therapeutics has mixed quality and excellent momentum. Taken together, the setup leans positive. Growth looks strong, which supports the long-term business case. We think Tg Therapeutics is selling at a high price, which cuts against the buy case.
What is the market capitalization of TGTX?
Tg Therapeutics's market capitalization is $8.48B.
What is the P/E ratio for TGTX stock?
Tg Therapeutics's current P/E ratio is 19.2.
What is the 52-week high for TGTX stock?
The 52-week high for Tg Therapeutics is $59.30. The current close of $55.39 is 6.6% below that high.
What is the 52-week low for TGTX stock?
The 52-week low for Tg Therapeutics is $26.76. The current close of $55.39 is 107% above that low.
Does TGTX stock pay dividends?
Tg Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for TGTX?
Tg Therapeutics's Debt / Equity ratio is 1.25.